ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003